JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4301
Inogen
INGN
$153M
| $497K | ﹤0.01% |
39,763
+2,846
| +8% | +$54.5K |
2014 Q1
36 quarters
|
|
|
JAMF
4302
DELISTED
Jamf
JAMF
| $496K | ﹤0.01% |
25,521
+3,778
| +17% | +$75.7K |
2020 Q3
10 quarters
|
|
|
PNT
4303
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $496K | ﹤0.01% |
68,242
-57,004
| -46% | -$423K |
2021 Q4
5 quarters
|
|
4304
Anavex Life Sciences
AVXL
$148M
| $495K | ﹤0.01% |
57,722
+13,748
| +31% | +$137K |
2019 Q2
15 quarters
|
|
4305
Alerian Energy Infrastructure ETF
ENFR
$540M
| $494K | ﹤0.01% |
+23,611
| New | +$505K |
2023 Q1
0 quarters
|
|
4306
First Internet Bancorp
INBK
$233M
| $494K | ﹤0.01% |
29,719
-71,984
| -71% | -$1.74M |
2017 Q3
22 quarters
|
|
|
NPKI
4307
NPK International
NPKI
$1.02B
| $494K | ﹤0.01% |
128,266
-100,095
| -44% | -$438K |
2016 Q4
25 quarters
|
|
4308
Xponential Fitness
XPOF
$204M
| $493K | ﹤0.01% |
16,220
+5,776
| +55% | +$153K |
2021 Q3
6 quarters
|
|
4309
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43B
| $492K | ﹤0.01% |
3,800
| – | – |
2021 Q4
5 quarters
|
|
|
4310
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43B
| $492K | ﹤0.01% |
3,800
-213,500
| -98% | -$27.9M |
2021 Q3
6 quarters
|
|
4311
PubMatic
PUBM
$836M
| $491K | ﹤0.01% |
35,565
+9,363
| +36% | +$135K |
2020 Q4
9 quarters
|
|
4312
Cadre Holdings
CDRE
$1.09B
| $491K | ﹤0.01% |
22,783
+4,883
| +27% | +$106K |
2021 Q4
5 quarters
|
|
4313
iShares US Consumer Discretionary ETF
IYC
$1.19B
| $489K | ﹤0.01% |
7,574
-2,206
| -23% | -$138K |
2013 Q2
39 quarters
|
|
|
IMTXW
4314
DELISTED
Immatics N.V. Warrants
IMTXW
| – | – |
0
| – | – |
2021 Q1
8 quarters
|
|
4315
Invesco KBW High Dividend Yield Financial ETF
KBWD
$357M
| $487K | ﹤0.01% |
33,026
+2,595
| +9% | +$41.2K |
2020 Q1
12 quarters
|
|
|
MLNK
4316
DELISTED
MeridianLink
MLNK
| $487K | ﹤0.01% |
28,157
+5,348
| +23% | +$86.1K |
2021 Q3
6 quarters
|
|
4317
PUT
Accenture
ACN
$118B
| $486K | ﹤0.01% |
1,700
-36,700
| -96% | -$10M |
2021 Q2
7 quarters
|
|
4318
Vera Bradley
VRA
$146M
| $483K | ﹤0.01% |
80,701
+30,627
| +61% | +$171K |
2022 Q4
1 quarter
|
|
4319
Ducommun
DCO
$2.65B
| $482K | ﹤0.01% |
8,804
+1,315
| +18% | +$71.7K |
2017 Q4
21 quarters
|
|
4320
Broadwind
BWEN
$101M
| $480K | ﹤0.01% |
+124,887
| New | +$532K |
2023 Q1
0 quarters
|
|
4321
Gevo
GEVO
$316M
| $480K | ﹤0.01% |
311,755
+50,680
| +19% | +$96K |
2019 Q4
13 quarters
|
|
4322
First Trust Technology AlphaDEX Fund
FXL
$2.94B
| $479K | ﹤0.01% |
4,550
+1,999
| +78% | +$202K |
2017 Q4
21 quarters
|
|
4323
Barrett Business Services
BBSI
$758M
| $478K | ﹤0.01% |
21,580
-1,300,284
| -98% | -$30.4M |
2013 Q2
39 quarters
|
|
4324
Aptus Enhanced Yield ETF
JUCY
$371M
| $478K | ﹤0.01% |
+19,174
| New | +$481K |
2023 Q1
0 quarters
|
|
4325
Mitsubishi UFJ Financial
MUFG
$261B
| $476K | ﹤0.01% |
74,652
+14,745
| +25% | +$103K |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.